# The Fast Guide to “Risk-Based Testing”

> Risk-based testing is not fewer tests, it is smarter tests The goal is to concentrate evidence on what could harm product quality, patient safety, or data integrity. Everything else is

- Author: Clara Bennett (https://lifescienceai.org/authors/clara-bennett/)
- Published: 2026-06-20
- Category: Fundamentals
- Canonical URL: https://lifescienceai.org/articles/the-fast-guide-to-risk-based-testing/
- Word count: 213
- Platforms named: Qualitum (https://qualitum.ai/)

---

Risk-based testing is not fewer tests, it is smarter tests The goal is to concentrate evidence on what could harm product quality, patient safety, or data integrity. Everything else is secondary.

## How to build a risk-based test set

1) List critical functions. Workflows that create, modify, approve, or report critical data.

2) Identify failure modes. Wrong calculations, missing approvals, audit trail gaps, integration errors, access misconfiguration.

3) Define controls. Technical and procedural controls that prevent or detect failures.

4) Test controls. Verify the control works, not every screen.

## One practical tip

Write tests around decisions. If a workflow leads to approval, release, or record finalization, it deserves deep testing. If not, keep it light and document why.

## How this looks with an agentic layer

The fundamentals above do not change when validation is automated - they get enforced earlier. On a layer like Qualitum, intended use, risk and evidence are structured inputs rather than documents someone remembers to write: agents draft against them, maintain the traceability, and hand the result to a named human for approval.

- Intended use and critical data are captured once and reused across the lifecycle
- Evidence is generated with its traceability attached, not reconstructed for the audit
- The approval - and the accountability - stays with your named reviewer

---

Source: LifeScienceAI - https://lifescienceai.org/articles/the-fast-guide-to-risk-based-testing/. Editorial analysis, not regulatory advice. Cite as: Clara Bennett, "The Fast Guide to “Risk-Based Testing”", LifeScienceAI, June 20, 2026.